{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_0", "document_index": 84, "latency_s": 0.8168218999926466, "prompt_toks": 6247, "completion_toks": 57}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    Cannabidiol\n\n(Redirected from CBD)\n\nSummary sheet: Cannabidiol\n\nCannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n\n                    Context: \n                    This excerpt provides a brief overview of cannabidiol (CBD), including its natural occurrence in cannabis, chemical diversity, and non-intoxicating effects, serving as an introductory summary within the comprehensive webpage covering CBD's chemistry, pharmacology, effects, medical use, and legal status.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_1", "document_index": 84, "latency_s": 0.7745785000006435, "prompt_toks": 6327, "completion_toks": 66}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    Cannabidiol  Purpose Chemical Nomenclature Common names Cannabidiol, CBD, Epidiolex Substitutive name Cannabidiol Systematic name (-)-trans-2-p-Mentha-1,8-dien-3-yl-5-pentylresorcinol Class Membership Psychoactive class Cannabinoid Chemical class Cannabinoid Routes of Administration WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section . ⇣ Oral Dosage Threshold 2 mg Light 5 - 15 mg Common 15 - 30 mg Strong 30 - 60 mg Heavy 60 mg + Duration Total 1.5 - 4 hours Come up 15 - 30 minutes Offset 1 - 1.5 hours DISCLAIMER : PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy. Interactions\n\n\n                    Context: \n                    This section provides an overview of cannabidiol's chemical nomenclature, common names, classification, and routes of administration, along with dosage guidelines and a disclaimer. It is a detailed reference within the broader webpage on cannabidiol, supporting users seeking specific information on its chemistry, dosing, and safe usage practices.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_2", "document_index": 84, "latency_s": 0.9733628999965731, "prompt_toks": 6309, "completion_toks": 77}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    Cannabidiol can be administered by multiple routes, including by inhalation of cannabis smoke or vapor, as an aerosol spray into the cheek, and by mouth. It may be supplied as CBD oil containing only CBD as the active ingredient (i.e. no added THC or terpenes), a full-plant CBD-dominant hemp extract oil, capsules, dried cannabis, or as a prescription liquid solution.[2]\n\nIn the United States, the cannabidiol drug Epidiolex is approved by the Food and Drug Administration for the treatment of epilepsy disorders.[3] The U.S. Drug Enforcement Administration has assigned Epidiolex a Schedule V classification, while non-Epidiolex CBD remains a Schedule I drug prohibited for any use.[4] Cannabidiol is not scheduled under any United Nations drug control treaties.[5]\n\nSubjective effects include anxiety suppression, muscle relaxation, and pain relief.\n\n\n                    Context: \n                    This excerpt details the common administration routes, legal status, and subjective effects of cannabidiol (CBD), highlighting specific preparations such as oils and prescription pharmaceuticals like Epidiolex. It provides essential information on legal classifications in the U.S. and the typical psychoactive effects experienced, situating it within the broader discussion of CBD’s pharmacology, medical use, and legal considerations.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_3", "document_index": 84, "latency_s": 0.9736080000002403, "prompt_toks": 6326, "completion_toks": 92}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    Subjective effects include anxiety suppression, muscle relaxation, and pain relief.\n\nCannabidiol is generally well-tolerated with a good safety profile.[6] However, it may have the potential to cause adverse drug-drug interactions. As a result, it is advised to use harm reduction practices if using this substance.\n\nContents\n\n1 History and culture\n\n1.1 Adulterated CBD-products\n\n2 Chemistry\n\n3 Pharmacology\n\n4 Subjective effects\n\n4.1 Physical effects\n\n4.2 Cognitive effects\n\n4.3 Experience reports\n\n5 Medical use\n\n5.1 Research\n\n5.2 Risks with vaped/smoked CBD\n\n6 Toxicity and harm potential\n\n6.1 Dependence and abuse potential\n\n6.2 Dangerous interactions\n\n7 Legal status\n\n8 External links\n\n9 Literature\n\n10 References\n\nHistory and culture\n\nThis History and culture section is a stub . As a result, it may contain incomplete or wrong information. You can help by expanding it .\n\n\n                    Context: \n                    This excerpt covers cannabidiol's subjective effects, safety profile, and the document's structural outline, including the main sections on pharmacology, medical use, toxicity, legal status, and historical background. It highlights key effects such as anxiety reduction, muscle relaxation, and pain relief, while noting its generally good safety profile and potential drug interactions. The content is integral to understanding CBD's effects, safety considerations, and the organization of information within the full webpage.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_4", "document_index": 84, "latency_s": 0.6857430999953067, "prompt_toks": 6320, "completion_toks": 72}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    9 Literature\n\n10 References\n\nHistory and culture\n\nThis History and culture section is a stub . As a result, it may contain incomplete or wrong information. You can help by expanding it .\n\nCannibidiol was first isolated from Mexican marijuana by Roger Adams and from Indian charas by Alexander Todd, both in 1940. On the basis of chemical degradation and correlation with cannabinol, a general structure was proposed. In 1963, Raphael Mechoulam isolated CBD from Lebanese hashish and established its structure and relative stereochemistry.[7] Its absolute stereochemistry was determined in 1967.[7]\n\nAdulterated CBD-products\n\nAt least 128 samples out of more than 350 tested by government labs in nine states, nearly all in the South, had 371 types of synthetic cannabinoids in products marketed as CBD. Half of the 28 tested CBD-vape products contained less than 0.3% CBD.[8]\n\nChemistry\n\n\n                    Context: \n                    This section provides historical, cultural, and chemical background on cannabidiol (CBD), highlighting its first isolation in 1940, structural elucidation by Raphael Mechoulam in the 1960s, and issues with adulterated CBD products containing synthetic cannabinoids, relevant to understanding CBD's origins, chemistry, and quality concerns discussed in the broader document.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_5", "document_index": 84, "latency_s": 0.8890316000033636, "prompt_toks": 6340, "completion_toks": 85}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    Chemistry\n\nCannabis contains more than 400 different chemical compounds, of which 61 are considered cannabinoids, a class of compounds that act upon endogenous cannabinoid receptors of the body.[9] CBD accounts for up to 41% of the plant's extract.[citation needed]\n\nCannabis produces CBD-carboxylic acid through the same metabolic pathway as THC, until the next to last step, where CBDA synthase performs catalysis instead of THCA synthase.[10]\n\nAt room temperature, cannabidiol is a colorless crystalline solid.[11] It is practically insoluble in water.[12]\n\nPharmacology\n\nThe exact mechanism of action of CBD and THC is not currently fully understood. However, it is known that CBD acts on cannabinoid (CB) receptors of the endocannabinoid system, which are found in numerous areas of the body, including the peripheral and central nervous systems (such as the brain)). The endocannabinoid system regulates many physiological responses of the body including pain, memory, appetite, and mood.\n\n\n                    Context: \n                    This excerpt covers the chemistry and pharmacology of cannabidiol (CBD), detailing its natural occurrence in cannabis, chemical production pathway, physical properties, and its action on the body's endocannabinoid system, highlighting its role in regulating pain, mood, and physiological responses. It provides foundational scientific information relevant to understanding CBD's molecular structure, sources, and biological mechanisms within the broader discussion of its effects and medical potential.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_6", "document_index": 84, "latency_s": 1.271028799994383, "prompt_toks": 6260, "completion_toks": 76}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    More specifically, CB1 receptors can be found within the pain pathways of the brain and spinal cord where they may affect CBD-induced analgesia and anxiolysis, and CB2 receptors have an effect on immune cells, where they may affect CBD-induced anti-inflammatory processes.[12] CBD has been shown to act as a negative allosteric modulator of the cannabinoid CB1 receptor, the most abundant G-Protein Coupled Receptor (GPCR) in the body.[13] Allosteric modulators differ from receptor agonists in that they alter the activity of the receptor by binding to a functionally distinct binding site rather than directly to the receptor.\n\n\n                    Context: \n                    This excerpt details the pharmacological mechanisms of CBD, specifically its interaction with cannabinoid receptors CB1 and CB2, including its role as a negative allosteric modulator of CB1. Understanding these receptor interactions is essential for comprehending CBD's effects on pain, inflammation, and anxiolysis, making this information highly relevant within the pharmacology section of the full document.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_7", "document_index": 84, "latency_s": 0.8791213999938918, "prompt_toks": 6387, "completion_toks": 82}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    In addition to the well-known activity on CB1 and CB2 receptors, there is further evidence that CBD also activates 5-HT1A/2A/3A serotonergic and TRPV1–2 vanilloid receptors, antagonizes alpha-1 adrenergic and µ-opioid receptors, inhibits synaptosomal uptake of noradrenaline, dopamine, serotonin and gamma-aminobutyric acid (GABA), and cellular uptake of anandamide, acts on mitochondria Ca2+ stores, blocks low-voltage-activated (T-type) Ca2+ channels, stimulates activity of the inhibitory glycine-receptor, and inhibits activity of fatty amide hydrolase (FAAH).[14][15]\n\nThe oral bioavailability of CBD is 13 to 19%, while its bioavailability via inhalation is 11 to 45% (mean 31%).[16][17] The elimination half-life of CBD is 18–32 hours.[18]\n\nCannabidiol is metabolized in the liver and intestines by enzymes CYP2C19 and CYP3A4, and UGT1A7, UGT1A9, and UGT2B7 isoforms.[19]\n\nSubjective effects\n\n\n                    Context: \n                    This section details the complex pharmacological mechanisms and bioavailability of cannabidiol (CBD), including its interactions with various receptors and metabolic pathways. It provides essential information on CBD’s activity on serotonergic, vanilloid, and other receptors, as well as its absorption, half-life, and liver metabolism, which are critical for understanding its effects, safety, and therapeutic potential within the comprehensive drug profile.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_8", "document_index": 84, "latency_s": 0.6196342000039294, "prompt_toks": 6323, "completion_toks": 62}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    Cannabidiol is metabolized in the liver and intestines by enzymes CYP2C19 and CYP3A4, and UGT1A7, UGT1A9, and UGT2B7 isoforms.[19]\n\nSubjective effects\n\nThis subjective effects section is a stub . As such, it is still in progress and may contain incomplete or wrong information. You can help by expanding or correcting it.\n\nDisclaimer: The effects listed below cite the Subjective Effect Index (SEI), an open research literature based on anecdotal user reports and the personal analyses of PsychonautWiki contributors. As a result, they should be viewed with a healthy degree of skepticism.\n\nIt is also worth noting that these effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects. Likewise, adverse effects become increasingly likely with higher doses and may include addiction, severe injury, or death ☠.\n\nPhysical effects\n\n\n                    Context: \n                    This excerpt covers the metabolic pathways of cannabidiol in the human body and provides an introduction to its subjective effects, noting the current lack of comprehensive data. This section is relevant for understanding CBD's pharmacokinetics and potential user experience, contributing to the overall safety and effects profile outlined in the full document.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_9", "document_index": 84, "latency_s": 0.9897793999989517, "prompt_toks": 6318, "completion_toks": 73}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    Physical effects\n\nAddiction suppression - There are some anecdotal reports that suggest CBD may have some addiction suppressing effects. However, this has not been subjected to rigorous clinical studies and more research is needed.\n\nMuscle relaxation - Some users report that CBD produces a mild to moderate degree of muscle relaxation that is weaker than that of benzodiazepines and muscle relaxants. However, other users do not experience this effect.\n\nPain relief\n\nSeizure suppression\n\nDiarrhea\n\nCognitive effects\n\nAddiction suppression\n\nAnxiety suppression\n\nMindfulness\n\nSleepiness - Sleepiness on CBD depends mostly on dose and/or strain of the plant (if using a full spectrum or hemp extract) and is most prominent after the peak subsides.\n\nExperience reports\n\nThere are currently no anecdotal reports which describe the effects of this compound within our experience index. Additional experience reports can be found here:\n\nErowid Experience Vaults: Cannabidiol\n\nMedical use\n\n\n                    Context: \n                    This excerpt details the physical and cognitive effects of cannabidiol (CBD), including anecdotal reports on muscle relaxation, pain relief, seizure suppression, and sleepiness, as well as noting the lack of formal experience data. It forms part of the broader section on CBD’s subjective effects and harm potential, providing practical insights into its plant-based effects and user experiences.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_10", "document_index": 84, "latency_s": 0.9617997000023024, "prompt_toks": 6320, "completion_toks": 94}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    Erowid Experience Vaults: Cannabidiol\n\nMedical use\n\nCannabidiol is currently approved in the United States under the name Epidiolex as a treatment for epilepsy disorders.[3]\n\nAt lower doses, some studies have shown cannabidiol to have various antioxidative, anti-inflammatory, and neuroprotective properties. For instance, CBD is more effective than vitamin C and E as a neuroprotective antioxidant and can ameliorate skin conditions such as acne.[20][21] It should be noted that cannabidiol has been the subject of sensational health claims in the popular media. A 2016 study found that there is only limited high-quality evidence for cannabidiol having any neurological effect in people.[22]\n\nResearch\n\nCBD is under preliminary research for its potential antipsychotic effect, possibly mitigating some of the negative, psychosis-like effects of THC.[23][24]\n\nRisks with vaped/smoked CBD\n\n\n                    Context: \n                    This excerpt provides an overview of cannabidiol’s medical uses, therapeutic properties, and research status, including its approved treatments like Epidiolex in the U.S., potential neuroprotective effects, and ongoing studies into its antipsychotic properties. It highlights key safety considerations such as limited high-quality evidence and risks associated with vaping or smoking CBD. This information complements the full webpage's comprehensive discussion on CBD’s pharmacology, legal status, and harm reduction.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_11", "document_index": 84, "latency_s": 0.8046555000037188, "prompt_toks": 6301, "completion_toks": 67}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    Research\n\nCBD is under preliminary research for its potential antipsychotic effect, possibly mitigating some of the negative, psychosis-like effects of THC.[23][24]\n\nRisks with vaped/smoked CBD\n\nFirstly: Vaped or smoked CBD heated to 250-300 C will partially be converted to THC.[25] Thus it's inconvenient to smoke or vape CBD to relieve a THC toxicity. Secondly: 50 times more CBD than THC is needed to reduce acute effects of THC,[26] which makes it practically impossible to administer proper dosage by inhalation. Also, the quantity of CBD converted into THC will increase a lot with the required ratio, and excessive harshness in the lungs may escalate a bad trip.\n\nToxicity and harm potential\n\nAccording to clinical studies, cannabidiol is well-tolerated and shows little to no toxicity.[27]\n\n\n                    Context: \n                    This section summarizes current research on cannabidiol’s potential antipsychotic effects, risks associated with vaping or smoking CBD (notably the conversion to THC at high temperatures), and its overall low toxicity profile based on clinical studies, highlighting both therapeutic prospects and safety considerations within the broader overview of CBD's pharmacology and harm potential.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_12", "document_index": 84, "latency_s": 0.7062845000036759, "prompt_toks": 6303, "completion_toks": 57}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    Toxicity and harm potential\n\nAccording to clinical studies, cannabidiol is well-tolerated and shows little to no toxicity.[27]\n\nIn a 2011 literature review, CBD was found to not alter physiological parameters such as heart rate, blood pressure, and body temperature. Moreover, psychological and psychomotor functions are not adversely affected. Chronic use and high doses of up to 1500 mg per day have been repeatedly shown to be well tolerated by humans. As a result, it is considered to have a good safety profile.[28] However, this information should be interpreted cautiously as cannabidiol has been subject to relatively few human studies; further research is needed to fully establish its safety profile.\n\nCommonly reported side effects from prescribed cannabidiol use include tiredness, diarrhea, and changes of appetite and weight.[29]\n\nDependence and abuse potential\n\n\n                    Context: \n                    This section discusses the toxicity, safety profile, and potential side effects of cannabidiol, highlighting its general tolerance, low toxicity, and minimal adverse effects based on clinical studies. It is essential for understanding the health risks and dependability of CBD as covered in the overall drug profile.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_13", "document_index": 84, "latency_s": 0.5899371999985306, "prompt_toks": 6311, "completion_toks": 55}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    Commonly reported side effects from prescribed cannabidiol use include tiredness, diarrhea, and changes of appetite and weight.[29]\n\nDependence and abuse potential\n\nCannabidiol is considered to have low abuse potential compared to THC and other recreational substances. Cannabidiol administration does not produce euphoria or other reinforcing effects and there is no evidence that use results in physical or psychological dependence.\n\nDangerous interactions\n\nThis dangerous interactions section is a stub . As such, it may contain incomplete or invalid information. You can help by expanding upon or correcting it.\n\nCannabidiol can be an inhibitor of CYP enzymes (including CYP3A4),[30] which are involved in the metabolism of many psychoactive substances. As a result, it has the potential to cause dangerous interactions. Caution is advised when combining cannabidiol with other substances, particularly with higher doses.\n\nLegal status\n\n\n                    Context: \n                    This excerpt covers the commonly reported side effects, dependence and abuse potential, dangerous interactions, and legal status of cannabidiol (CBD), providing essential safety and legal information that complements the broader discussion of CBD's pharmacology, effects, and medical use in the webpage.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_14", "document_index": 84, "latency_s": 0.829843700004858, "prompt_toks": 6301, "completion_toks": 75}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    Legal status\n\nInternationally, cannabidiol is not scheduled under the Convention on Psychotropic Substances or any other UN drug treaty.\n\nAustralia: Cannabidiol (in preparations for therapeutic use containing 2 per cent or less of other cannabinoids found in cannabis) was placed in Schedule 4 as a \"Prescription Only Medicine OR Prescription Animal Remedy\" in 2015. It was previously listed in Schedule 9 as a prohibited substance.[31]\n\nCanada: Cannabidiol is specifically listed in the Schedule II Controlled Drugs and Substances Act. However, in 2016 Canada’s \"Access to Cannabis for Medical Purposes Regulations\" came into effect. These regulations improve access to cannabis used for medicinal purposes, including CBD.[32]\n\nHong Kong: Illegal in Hong Kong since 1st February 2023, punishable by 7 years imprisonment.[33]\n\n\n                    Context: \n                    This section provides an overview of the international and national legal statuses of cannabidiol (CBD), detailing its scheduling and legal restrictions in various countries. It highlights regions where CBD is legal, regulated, or illegal, and specifies recent changes in jurisdictions like Australia, Canada, and Hong Kong. This information is crucial for understanding the legal considerations associated with CBD use and distribution worldwide.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_15", "document_index": 84, "latency_s": 0.8761873999901582, "prompt_toks": 6320, "completion_toks": 72}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    Hong Kong: Illegal in Hong Kong since 1st February 2023, punishable by 7 years imprisonment.[33]\n\nNew Zealand: Cannabidiol is a controlled substance in New Zealand. However, by passing the Misuse of Drugs Amendment Regulations 2017 in September 2017, many of the restrictions currently imposed by the regulations are removed since then. The changes will mean that CBD products, where the level of other naturally occurring cannabinoids is less than 2% of the cannabinoid content, will be easier to access for medical use.[34]\n\nSwitzerland: Cannabidiol is not subject to the Narcotics Act in Switzerland because it does not produce a psychoactive effect. It is still subject to standard Swiss legislation.[35]\n\nUnited Kingdom: In 2016, the Medicines and Healthcare products Regulatory Agency (MHRA) issued a statement that products containing CBD used for medical purposes are considered as a medicine subject to standard licensing requirements.[36]\n\n\n                    Context: \n                    This excerpt summarizes the legal status of cannabidiol (CBD) in various countries, highlighting recent regulations and enforcement. It details restrictions and allowances in Hong Kong, New Zealand, Switzerland, and the United Kingdom, providing key regulatory updates relevant to understanding CBD's legal landscape globally. This information is essential for users seeking legal guidance on CBD use across different jurisdictions.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_16", "document_index": 84, "latency_s": 0.7780542999971658, "prompt_toks": 6422, "completion_toks": 80}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    United States: Cannabidiol is legal under the 2018 Farm Bill[37]. The rest of the cannabis plant (anything with more than 0.3% Delta-9-THC) is still under Schedule I of the Controlled Substances Act.[citation needed]\n\nExternal links\n\nCannabidiol (Wikipedia)\n\nCannabidiol (Isomer Design)\n\nCannabidiol (Drugs-Forum)\n\nProject CBD\n\nLiterature\n\nMechoulam, R., Peters, M., Murillo-Rodríguez, E., & Hanuš, L.O. (2007). Cannabidiol--recent advances. Chemistry & Biodiversity, 4 8, 1678-92.\n\nMechoulam, R., Parker, L. A., & Gallily, R. (2002). Cannabidiol: an overview of some pharmacological aspects. The Journal of Clinical Pharmacology, 42(S1).\n\nDevinsky, O., Cilio, M. R., Cross, H., Fernandez‐Ruiz, J., French, J., Hill, C., ... & Martinez‐Orgado, J. (2014). Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia, 55(6), 791-802. https://doi.org/0.1111/epi.12631\n\nReferences\n\n\n                    Context: \n                    This chunk provides information on the legal status of cannabidiol in the United States, highlighting its legality under the 2018 Farm Bill and its classification under Schedule I of the Controlled Substances Act. It also includes external links and key literature references relevant to cannabidiol research and regulation, complementing the overall focus on CBD's effects, safety, and legal considerations within the full document.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_17", "document_index": 84, "latency_s": 0.5436048999981722, "prompt_toks": 6387, "completion_toks": 45}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    References\n\n↑ Campos, A. C., Moreira, F. A., Gomes, F. V., Del Bel, E. A., Guimarães, F. S. (5 December 2012). \"Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders\". Philosophical Transactions of the Royal Society B: Biological Sciences. 367 (1607): 3364–3378. doi:10.1098/rstb.2011.0389. ISSN 0962-8436.\n\n↑ \"Epidiolex (Cannabidiol) FDA Label\" (PDF). fda.gov. Retrieved 28 June 2018. For label updates see FDA index page for NDA 210365\n\n↑ 3.0 3.1 FDA Approves First Drug Comprised of an Active Ingredient Derived from Marijuana to Treat Rare, Severe Forms of Epilepsy, 2018, retrieved 25 June 2018\n\n↑ LaVito, A., DEA reschedules Epidiolex, marijuana-derived drug, paving the way for it to hit the market\n\n↑ Angell, T. (2018), UN Launches First-Ever Full Review Of Marijuana’s Status Under International Law\n\n\n                    Context: \n                    This references section lists key scientific studies and official sources related to cannabidiol's mechanisms, medical approvals, and legal status, providing foundational evidence supporting the informational content of the full document on cannabidiol (CBD).\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_18", "document_index": 84, "latency_s": 0.6062388999998802, "prompt_toks": 6408, "completion_toks": 51}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    ↑ Angell, T. (2018), UN Launches First-Ever Full Review Of Marijuana’s Status Under International Law\n\n↑ Iffland, Kerstin; Grotenhermen, Franjo (2017). \"An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies\". Cannabis and Cannabinoid Research. 2 (1): 139–154. doi:10.1089/can.2016.0034. ISSN 2378-8763.\n\n↑ 7.0 7.1 Mechoulam, R., Hanuš, L. (December 2002). \"Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects\". Chemistry and Physics of Lipids. 121 (1–2): 35–43. doi:10.1016/S0009-3084(02)00144-5. ISSN 0009-3084.\n\n↑ How the Associated Press collected information on CBD vapes, 2019\n\n↑ Sharma, P., Murthy, P., Bharath, M. M. S. (2012). \"Chemistry, metabolism, and toxicology of cannabis: clinical implications\". Iranian Journal of Psychiatry. 7 (4): 149–156. ISSN 1735-4587.\n\n\n                    Context: \n                    This excerpt lists key academic and industry references related to cannabidiol (CBD), including scholarly reviews on its safety and side effects, chemical properties, and research developments, providing authoritative sources within the broader comprehensive overview of CBD covered in the full webpage content.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_19", "document_index": 84, "latency_s": 0.8356613999931142, "prompt_toks": 6422, "completion_toks": 80}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    ↑ Sharma, P., Murthy, P., Bharath, M. M. S. (2012). \"Chemistry, metabolism, and toxicology of cannabis: clinical implications\". Iranian Journal of Psychiatry. 7 (4): 149–156. ISSN 1735-4587.\n\n↑ Marks, M. D., Tian, L., Wenger, J. P., Omburo, S. N., Soto-Fuentes, W., He, J., Gang, D. R., Weiblen, G. D., Dixon, R. A. (September 2009). \"Identification of candidate genes affecting Δ9-tetrahydrocannabinol biosynthesis in Cannabis sativa\". Journal of Experimental Botany. 60 (13): 3715–3726. doi:10.1093/jxb/erp210. ISSN 1460-2431.\n\n↑ Jones, P. G., Falvello, L., Kennard, O., Sheldrick, G. M., Mechoulam, R. (1 October 1977). \"Cannabidiol\". Acta Crystallographica Section B Structural Crystallography and Crystal Chemistry. 33 (10): 3211–3214. doi:10.1107/S0567740877010577. ISSN 0567-7408.\n\n↑ 12.0 12.1 Cannabidiol, DrugBank\n\n\n                    Context: \n                    This collection of references provides foundational scientific literature on the chemistry, biosynthesis, and structural properties of cannabidiol, supporting the detailed pharmacological and chemical sections of the full webpage. It includes studies on cannabis metabolism, gene identification related to THC synthesis, and crystallography of cannabidiol, offering essential background data relevant to understanding CBD's molecular characteristics and its role within cannabis research.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_20", "document_index": 84, "latency_s": 0.693827399998554, "prompt_toks": 6422, "completion_toks": 57}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    ↑ 12.0 12.1 Cannabidiol, DrugBank\n\n↑ Laprairie, R. B., Bagher, A. M., Kelly, M. E. M., Denovan-Wright, E. M. (October 2015). \"Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor: Negative allosteric modulation of CB 1 by cannabidiol\". British Journal of Pharmacology. 172 (20): 4790–4805. doi:10.1111/bph.13250. ISSN 0007-1188.\n\n↑ Ibeas Bih, C., Chen, T., Nunn, A. V. W., Bazelot, M., Dallas, M., Whalley, B. J. (October 2015). \"Molecular Targets of Cannabidiol in Neurological Disorders\". Neurotherapeutics. 12 (4): 699–730. doi:10.1007/s13311-015-0377-3. ISSN 1933-7213.\n\n↑ Zhornitsky, S., Potvin, S. (21 May 2012). \"Cannabidiol in Humans—The Quest for Therapeutic Targets\". Pharmaceuticals. 5 (5): 529–552. doi:10.3390/ph5050529. ISSN 1424-8247.\n\n\n                    Context: \n                    This excerpt provides key scientific references on cannabidiol’s pharmacological mechanisms, molecular targets, and therapeutic potential, supporting the detailed pharmacology and medical use sections of the overall document. These sources offer in-depth research findings and scholarly validation related to CBD’s receptor interactions and clinical applications.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_21", "document_index": 84, "latency_s": 0.6151074999943376, "prompt_toks": 6388, "completion_toks": 56}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    ↑ Zhornitsky, S., Potvin, S. (21 May 2012). \"Cannabidiol in Humans—The Quest for Therapeutic Targets\". Pharmaceuticals. 5 (5): 529–552. doi:10.3390/ph5050529. ISSN 1424-8247.\n\n↑ Scuderi, C., Filippis, D. D., Iuvone, T., Blasio, A., Steardo, A., Esposito, G. (May 2009). \"Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders: CANNABIDIOL IN CNS DISORDERS\". Phytotherapy Research. 23 (5): 597–602. doi:10.1002/ptr.2625. ISSN 0951-418X.\n\n↑ Mechoulam, R., Parker, L. A., Gallily, R. (November 2002). \"Cannabidiol: An Overview of Some Pharmacological Aspects\". The Journal of Clinical Pharmacology. 42 (S1): 11S–19S. doi:10.1002/j.1552-4604.2002.tb05998.x. ISSN 0091-2700.\n\n\n                    Context: \n                    This excerpt references key scientific reviews and pharmacological overviews of cannabidiol, highlighting its therapeutic potential and mechanisms of action in human CNS disorders. These citations provide foundational research that supports the detailed sections on CBD's effects, safety profile, and medicinal use within the full webpage.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_22", "document_index": 84, "latency_s": 0.6165110000001732, "prompt_toks": 6432, "completion_toks": 50}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    ↑ Devinsky, O., Cilio, M. R., Cross, H., Fernandez-Ruiz, J., French, J., Hill, C., Katz, R., Di Marzo, V., Jutras-Aswad, D., Notcutt, W. G., Martinez-Orgado, J., Robson, P. J., Rohrback, B. G., Thiele, E., Whalley, B., Friedman, D. (June 2014). \"Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders\". Epilepsia. 55 (6): 791–802. doi:10.1111/epi.12631. ISSN 0013-9580.\n\n↑ \"Epidiolex (Cannabidiol) FDA Label\" (PDF). fda.gov. Retrieved 28 June 2018. For label updates see FDA index page for NDA 210365\n\n↑ Hampson, A. J., Grimaldi, M., Axelrod, J., Wink, D. (7 July 1998). \"Cannabidiol and (−)Δ 9 -tetrahydrocannabinol are neuroprotective antioxidants\". Proceedings of the National Academy of Sciences. 95 (14): 8268–8273. doi:10.1073/pnas.95.14.8268. ISSN 0027-8424.\n\n\n                    Context: \n                    This chunk provides key scientific references supporting cannabidiol's pharmacological properties, therapeutic potential in neurological disorders, and neuroprotective effects. It highlights studies and regulatory labels essential for understanding CBD’s medical research basis and safety profile within the full document.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_23", "document_index": 84, "latency_s": 0.6680701999866869, "prompt_toks": 6496, "completion_toks": 80}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    ↑ Oláh, A., Tóth, B. I., Borbíró, I., Sugawara, K., Szöllõsi, A. G., Czifra, G., Pál, B., Ambrus, L., Kloepper, J., Camera, E., Ludovici, M., Picardo, M., Voets, T., Zouboulis, C. C., Paus, R., Bíró, T. (2 September 2014). \"Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes\". Journal of Clinical Investigation. 124 (9): 3713–3724. doi:10.1172/JCI64628. ISSN 0021-9738.\n\n↑ Prud'homme M, Cata R, Jutras-Aswad D (2015). \"Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence\". Substance Abuse. 9: 33–8. doi:10.4137/SART.S25081. PMC 4444130 . PMID 26056464.\n\n↑ Hudson R, Renard J, Norris C, Rushlow WJ, Laviolette SR (October 2019). \"Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation\". The Journal of Neuroscience. 39 (44): 8762–8777. doi:10.1523/JNEUROSCI.0708-19.2019. PMC 6820200 . PMID 31570536.\n\n\n                    Context: \n                    This chunk presents recent scientific research on cannabidiol’s various biological effects, including its anti-inflammatory, anti-sebostatic, and anti-addictive properties, as well as its ability to counteract THC’s side effects. These studies support the document’s overview of cannabidiol’s pharmacology, medical potential, and safety profile, providing evidence-based insights relevant for users and researchers.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_24", "document_index": 84, "latency_s": 1.3235749000014039, "prompt_toks": 6478, "completion_toks": 106}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    \"Cannabis study reveals how CBD offsets the psychiatric side-effects of THC\". ScienceDaily (Press release). September 30, 2019.\n\n↑ https://www.scielo.br/j/bjmbr/a/5sGSHxqFkYHxCYhRZh6fWKH/?format=pdf&lang=en. Missing or empty |title= (help)\n\n↑ Czégény, Z; Nagy, G; Babinszki, B; Bajtel, Á; Sebestyén, Z; Kiss, T; Csupor-Löffler, B; Tóth, B; Csupor, D (26 April 2021). \"CBD, a precursor of THC in e-cigarettes\". Scientific reports. 11 (1): 8951. doi:10.1038/s41598-021-88389-z. PMC 8076212 Check |pmc= value (help). PMID 33903673.\n\n↑ Englund, A., Oliver, D., Chesney, E., Chester, L., Wilson, J., Sovi, S., De Micheli, A., Hodsoll, J., Fusar-Poli, P., Strang, J., Murray, R. M., Freeman, T. P., McGuire, P. (16 November 2022). \"Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios\". Neuropsychopharmacology: 1–8. doi:10.1038/s41386-022-01478-z. ISSN 1740-634X. Retrieved 25 November 2022.\n\n\n                    Context: \n                    This excerpt highlights recent research on how cannabidiol (CBD) can counteract the psychiatric side effects of THC, including findings from a 2019 ScienceDaily article and a 2022 neuropsychopharmacology study examining different CBD:THC ratios to improve cannabis safety. It provides scientific evidence supporting CBD's role in modulating THC's adverse effects, relevant to the document's overview of CBD's pharmacology, effects, and harm reduction potential. The references emphasize CBD’s potential to influence cannabis-related mental health outcomes.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_25", "document_index": 84, "latency_s": 0.5940716000040993, "prompt_toks": 6393, "completion_toks": 63}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    ↑ Cunha, J. M., Carlini, E. A., Pereira, A. E., Ramos, O. L., Pimentel, C., Gagliardi, R., Sanvito, W. L., Lander, N., Mechoulam, R. (1980). \"Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients\". Pharmacology. 21 (3): 175–185. doi:10.1159/000137430. ISSN 1423-0313.\n\n↑ Bergamaschi, M. M., Queiroz, R. H. C., Zuardi, A. W., Crippa, J. A. S. \"Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent\". Current Drug Safety. 6 (4): 237–249.\n\n↑ Iffland, K., Grotenhermen, F. (January 2017). \"An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies\". Cannabis and Cannabinoid Research. 2 (1): 139–154. doi:10.1089/can.2016.0034. ISSN 2378-8763.\n\n\n                    Context: \n                    This chunk cites key scientific studies on the safety and side effects of cannabidiol, supporting the document's section on toxicity and harm potential, including research on its long-term administration and adverse effects. It provides references for clinical data indicating cannabidiol's safety profile, crucial for users seeking evidence-based information.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_26", "document_index": 84, "latency_s": 0.8582372999953805, "prompt_toks": 6423, "completion_toks": 60}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    ↑ Yamaori, Satoshi; Ebisawa, Juri; Okushima, Yoshimi; Yamamoto, Ikuo; Watanabe, Kazuhito (2011). \"Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: Role of phenolic hydroxyl groups in the resorcinol moiety\". Life Sciences. 88 (15-16): 730–736. doi:10.1016/j.lfs.2011.02.017. ISSN 0024-3205.\n\n↑ Australian Government Department of Health Therapeutic Goods Administration. (2017, August 1). Retrieved from https://www.tga.gov.au/book/part-final-decisions-matters-referred-expert-advisory-committee-2\n\n↑ Consolidated federal laws of Canada, Controlled Drugs and Substances Act\n\n↑ https://hongkongfp.com/2023/02/01/cannabis-compound-cbd-now-banned-in-hong-kong-7-year-jail-term-for-possession-to-match-meth-cocaine/\n\n↑ Medicinal Cannabis Agency - Cannabidiol (CBD) products\n\n↑ Swiss Agency for Therapeutic Products. (2017, August 1). Retrieved from https://www.swissmedic.ch/aktuell/00673/03778/index.html?lang=en\n\n↑ MHRA statement on products containing Cannabidiol (CBD)\n\n\n                    Context: \n                    This chunk consists of references and legal sources related to cannabidiol’s (CBD) inhibition of cytochrome P450 enzymes, international legal classifications, and regulatory bodies' guidelines. It provides supporting citations for sections discussing CBD's pharmacology, legal status, and harm potential within the full webpage.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_27", "document_index": 84, "latency_s": 0.9288439999945695, "prompt_toks": 6245, "completion_toks": 61}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    ↑ Swiss Agency for Therapeutic Products. (2017, August 1). Retrieved from https://www.swissmedic.ch/aktuell/00673/03778/index.html?lang=en\n\n↑ MHRA statement on products containing Cannabidiol (CBD)\n\n↑ https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd#farmbill\n\nRetrieved from ‘https://psychonautwiki.org/w/index.php?title=Cannabidiol&oldid=162054’\n\n\n                    Context: \n                    This chunk contains references to regulatory sources and official statements relevant to cannabidiol's legal status and safety assessments, including the Swiss Agency for Therapeutic Products, MHRA, and FDA. These citations support the document's section on legal status and safety considerations, providing authoritative sources for regulatory information on CBD.\n                "}
